Life Sciences / Pharmaceuticals
Life Science organizations are distinguished by a unique set of risks. Whether it is the discovery and development of a new drug, or the manufacture and delivery of existing products, the industry is susceptible to losses that can easily turn from minor to catastrophic. The Willis life sciences group provides risk avoidance and containment solutions for organizations in the biotechnology, pharmaceutical, medical device, and research fields. Our dedicated life sciences team works with clients to develop and implement risk management plans best suited to an organization's needs and goals.
Today's corporate governance standards require companies to have a well thought out operations liability and asset protection management strategy that appropriately blends physical, engineered and institutional risk controls - including insurance and alternative risk transfer solutions and mechanisms - to eliminate, control or mitigate exposures and their financial consequences. life science organizations also face specific and difficult risks in the areas of product development, intellectual asset protection (e.g. patent infringement and the theft of trade secrets), and often have a need to be served on a worldwide basis. The Willis life sciences client advocate serves as the portal to effective solutions for those risks.
Your company could benefit from our life sciences group if: